✦ LIBER ✦

P980 Liposomal amphotericin B standard dose in combination with caspofungin versus liposomal amphotericin B high dose regimen for the treatment of invasive aspergillosis in immunocom-promised patients: randomised pilot study (Combistrat Trial)

✍ Scribed by D. Caillot; A. Thiébaut; R. Herbrecht; A. Pigneux; S. de Botton; M. Attal; F. Bernard; J. Larché; S. Alfandari; F. Monchecourt; L. Mahi

Book ID: 119564962
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 52 KB
Volume: 29
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(07)70821-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liposomal amphotericin B in combination

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies : A randomized pilot study (Combistrat trial)

✍ Denis Caillot; Anne Thiébaut; Raoul Herbrecht; Stéphane de Botton; Arnaud Pigneu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds. ## METHODS. Patients with proven or probable IA were randomized in a